tiprankstipranks
Trending News
More News >

Lee’s Pharmaceutical Reports Robust Financial Growth in 2024

Story Highlights
Lee’s Pharmaceutical Reports Robust Financial Growth in 2024

Don’t Miss TipRanks’ Half-Year Sale

An announcement from Lee’s Pharmaceutical Holdings Limited ( (HK:0950) ) is now available.

Lee’s Pharmaceutical Holdings Limited announced a substantial financial performance improvement for the year ended December 31, 2024. The company reported a 32.9% increase in revenue and a 457.5% rise in profit attributable to owners compared to the previous year. This significant growth is reflected in the earnings per share, which also saw a dramatic increase. The Board has recommended a final dividend of HK2.5 cents per share, highlighting confidence in the company’s financial health and future prospects.

More about Lee’s Pharmaceutical Holdings Limited

Lee’s Pharmaceutical Holdings Limited is a company incorporated in the Cayman Islands, operating primarily in the pharmaceutical industry. It focuses on developing, manufacturing, and marketing pharmaceutical products, with a significant emphasis on the Asian market.

Average Trading Volume: 285,012

Technical Sentiment Signal: Sell

Current Market Cap: HK$836.1M

For an in-depth examination of 0950 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1